Amid a surge of targeted cancer meds, AstraZeneca, Amgen and Roche lead team promoting biomarker testing

Amid a surge of targeted cancer meds, AstraZeneca, Amgen and Roche lead team promoting biomarker testing
sharon.coey
Thu, 04/29/2021 – 07:13